Literature DB >> 4097283

Reversible left-ventricular failure in angina pectoris.

B Sharma, S H Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4097283     DOI: 10.1016/s0140-6736(70)92071-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris.

Authors:  B Sharma; P A Majid; M K Meeran; W Whitaker; S H Taylor
Journal:  Br Heart J       Date:  1972-06

2.  Angina pectoris.

Authors:  S H Taylor
Journal:  Br Med J       Date:  1971-06-19

3.  Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.

Authors:  D J Heterington; M B Comerford; G Nyberg; E M Besterman
Journal:  Br Heart J       Date:  1973-03

4.  Immediate and long-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.

Authors:  C A Visser; W Jaarsma; G Kan; J J Koolen; K I Lie
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Imbalanced ventricles and cardiac failure.

Authors: 
Journal:  Br Med J       Date:  1978-02-11

6.  Central haemodynamics during spontaneous angina pectoris.

Authors:  H Lecerof
Journal:  Br Heart J       Date:  1974-11

7.  Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.

Authors:  B Silke; S P Verma; M A Frais; M Hafizullah; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Comparison of adrenergic beta-blocking drugs in angina pectoris.

Authors:  B Sharma; M K Meeran; M C Galvin; A T Tulpule; W Whitaker; S H Taylor
Journal:  Br Med J       Date:  1971-07-17

Review 9.  Therapeutic targets in ischaemic heart disease.

Authors:  S H Taylor
Journal:  Drugs       Date:  1992       Impact factor: 9.546

10.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors:  B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.